key: cord-0933927-yb2vhrgp
authors: Wang, Yumin; Wang, Yanchao; Li, Xiujun; Wang, Hongquan
title: Re: Towards a deeper understanding of the dynamics of COVID-19-associated Guillain-Barre syndrome
date: 2021-07-07
journal: QJM
DOI: 10.1093/qjmed/hcab188
sha: 58db301527461e138db70e6e2633d700b8b14b6f
doc_id: 933927
cord_uid: yb2vhrgp

nan

Dear Editor, We appreciate the interest regarding ''SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease '' 1 by Dr. Jolobe (QJM-2021-946 # ).

We identified a total of 44 GBS patients with confirmed SARS-CoV-2 infection (SARS-CoV-2-GBS)，which were published between January 1, 2020 and June 26.

While, the research by Sheikh and and his colleagues included GBS associated with COVID-19 articles published from January 1st 2020 to September 15th 2020 2 .

After carefully examined the Supplementary data to this article 2 , we found that (72.7%) in our study 1 , which is more higher than that in this study 2 .The diagnosis was confirmed by serological testing in 5 (11.4%) of the 44 cases in our study 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   Availability of data and material: all data reported are available from the   corresponding author  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 

SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease

Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review

SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome

Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2

Manuscripts submitted to QJM

Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID-19

Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster

Manuscripts submitted to QJM

The author declares no conflict of interest. 

Hongquan Wang had full access to all the data in this study and take complete responsibility for the integrity of the data and the accuracy of the data analysis. All authors agree to be accountable for all aspects of the work by ensuring that questions related to the accuracy or integrity of any part of the work will be appropriately investigated and resolved. Final approval: All authors.